Correction to: The mechanism of VCP‑mediated metastasis of osteosarcoma based on cell autophagy and the EMT pathway

Correction to: Clinical and Translational Oncology (2023) 25:653–661 https://doi.org/10.1007/s12094-022-02972-y

In this article Figs. 4b and 5b were published in low quality and they are now replaced with the better-quality versions. The corrected figures (Figs. 4 and 5) are provided below.

Fig. 4

The effect of autophagy on the phenotype of OS cells. Autophagy inhibitors and agonists were used to change the autophagy level of OS cells. Including migration (A, scale bar = 200 μm) and invasion (B, scale bar = 200 μm), and count cells to evaluate the ability of the cells to resist anoikis (C, D). (N = 6. Data are presented as the mean ± standard deviation. *P < 0.05 vs. blank. ^#P < 0.05 vs. blank, OS cells not treated. Au-inhibitor, OS cells transfected with an autophagy inhibitor. Au-agonist, OS cells transfected with autophagy agonist)

Fig. 5

The effect of EMT on the phenotype of OS cells. EMT inhibitors and agonists were used to change the EMT level of OS cells. Including migration (A, scale bar = 200 μm) and invasion (B, scale bar = 200 μm) ability. The cell count ratio across the chamber relative to the blank group (C, D). (Blank, OS cells not treated. EMT inhibitor, OS cells transfected with EMT inhibitor. EMT agonist, OS cells transfected with EMT agonist. EMT epithelial to mesenchymal transition)

The original article has been corrected.